NCT06884839Completed
Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis
Source: ClinicalTrials.gov · Last updated 27 May 2026
Brief summary (registry, in English)
This study aims to evaluate the tumor deposits in colorectal cancer and its prognostic value in survival and metastasis
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 30 (actual)
- First submitted
- 13 Mar 2025
- Start date
- 1 Apr 2022
- Primary completion date
- 1 Apr 2023
- Lead sponsor
- Minia University
- Diseases
- Colorectal cancer
- NCT number
- NCT06884839
What you commit to
- Study type: Observational
- Participants enrolled: 30
- From 1 Apr 2022 to the primary completion date, 1 Apr 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient took neoadjuvant therapy.
Other illness
- Colorectal cancer is not the only primary cancer.
Other
- No information available on tumor deposits.
- Patients with incomplete information about follow-up.
Who the study is looking for
- Age above 18 years old.
- Both sexes.
- All Colorectal cancer patients From Stage I to III Colorectal cancer with pathologically positive Tumor deposits.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Minia University Coordinator of this site? Confirm its status | Minya | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.